Source: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, HIV, CITOCROMO P-450, GENÓTIPOS, INFECÇÕES POR HIV, FARMACOGENÉTICA, POLIMORFISMO
ABNT
XIMENEZ, João Paulo Bianchi et al. Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort. British Journal of Clinical Pharmacology, v. 88, n. 10, p. 4585-4594, 2022Tradução . . Disponível em: https://doi.org/10.1111/bcp.15387. Acesso em: 18 nov. 2024.APA
Ximenez, J. P. B., Elias, A. B. R., Nardotto, G. H. B., Barroso, P. F., Bollela, V. R., Lanchote, V. L., & Suarez-Kurtz, G. (2022). Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort. British Journal of Clinical Pharmacology, 88( 10), 4585-4594. doi:10.1111/bcp.15387NLM
Ximenez JPB, Elias ABR, Nardotto GHB, Barroso PF, Bollela VR, Lanchote VL, Suarez-Kurtz G. Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort [Internet]. British Journal of Clinical Pharmacology. 2022 ; 88( 10): 4585-4594.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/bcp.15387Vancouver
Ximenez JPB, Elias ABR, Nardotto GHB, Barroso PF, Bollela VR, Lanchote VL, Suarez-Kurtz G. Pharmacogenetic predictors of variability in efavirenz pharmacokinetics in an admixed Brazilian HIV cohort [Internet]. British Journal of Clinical Pharmacology. 2022 ; 88( 10): 4585-4594.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/bcp.15387